Safety and Efficiency of γδ T Cell Against Liver Cancer

NCT03183219 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators